Cellectis S.A. (CLLS)
NASDAQ·Healthcare·Biotechnology
$3.10
+0.32%
Mkt Cap $361.10M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$6.00
Range $4.00 – $8.00
Implied Upside
+93.5%
Consensus $6.00 vs current $3.10
NASDAQ·Healthcare·Biotechnology
$3.10
+0.32%
Mkt Cap $361.10M
No recent rating data.
Price Target (2 analysts)
$6.00
Range $4.00 – $8.00
+93.5%
Consensus $6.00 vs current $3.10